These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3010525)

  • 21. Clinical studies with treated clotting factor concentrates.
    Colombo M; Mannucci PM
    Dev Biol Stand; 1987; 67():333-6. PubMed ID: 3038639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human retroviral env and gag polypeptides: serologic assays to measure infection.
    Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS
    J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HTLV III and hepatitis A and B serological markers among U.S. military venereal disease patients.
    James JJ; Morgenstern M; Hatten JA; Koch MA
    Mil Med; 1986 Apr; 151(4):193-8. PubMed ID: 3010187
    [No Abstract]   [Full Text] [Related]  

  • 24. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
    Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
    Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevalence of hepatitis B surface antigen and its antibody in hospitalized patients of 2 psychiatric hospitals].
    Focaccia R; Veronesi R; Takeda A; Bazone JR; Rodrigues E; Mazza CC; Kimura RT; Feldman C
    Rev Inst Med Trop Sao Paulo; 1982; 24(6):385-7. PubMed ID: 7182915
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibodies to HTLV-III/LAV in Venezuelan patients with acute malarial infections.
    Volsky DJ; Wu YT; Stevenson M; Dewhurst S; Sinangil F; Merino F; Rodriguez L; Godoy G
    N Engl J Med; 1986 Mar; 314(10):647-8. PubMed ID: 3511375
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anti-HTLV-III in hemophilic patients in Barcelona].
    Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
    Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
    [No Abstract]   [Full Text] [Related]  

  • 28. Pyoderma gangrenosum in a patient with HTLV-III antibody.
    Schwartz BK; Clendenning WE; Blasik LG
    Arch Dermatol; 1986 May; 122(5):508-9. PubMed ID: 3010887
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of antibody to HTLV-III by commercial kits.
    O'Shaughnessy MV; Benning BJ; Neumann PW
    CMAJ; 1985 Sep; 133(6):551, 555. PubMed ID: 2992733
    [No Abstract]   [Full Text] [Related]  

  • 30. Receptors for polymerized human serum albumin and other hepatitis B virus markers during acute hepatitis B--predictive value of the outcome of the disease.
    Mora I; Porres JC; Bartolome FJ; Hernandez Guio C; Gutiez J; Carreño V
    Hepatogastroenterology; 1986 Dec; 33(6):250-4. PubMed ID: 3026941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infection by HTLV III virus in Chilean homosexuals of median and high socioeconomic levels].
    Velasco M; Sepúlveda C; Hurtado C
    Rev Med Chil; 1986 Sep; 114(9):823-7. PubMed ID: 3033791
    [No Abstract]   [Full Text] [Related]  

  • 32. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus.
    Perrillo RP; Regenstein FG; Roodman ST
    Ann Intern Med; 1986 Sep; 105(3):382-3. PubMed ID: 3017169
    [No Abstract]   [Full Text] [Related]  

  • 34. [Viral markers of acute hepatitis].
    Jirón MI; Armas Merino R; Ramón Soto J; Wolff C
    Rev Med Chil; 1982 Dec; 110(12):1234-6. PubMed ID: 7184111
    [No Abstract]   [Full Text] [Related]  

  • 35. [Human T-cell leukemia (lymphoma) virus (HTLV-I) antibodies in Danish patients with cutaneous T-cell lymphoma].
    Wantzin GL
    Hautarzt; 1986 May; 37(5):263-5. PubMed ID: 3015842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Incidence and significance of antibodies to hepatitis delta-antigen in hepatitis B viral infection].
    Jelić O; Jelić D; Balen I; Mihaljević I; Dominis M
    Acta Med Iugosl; 1987; 41(2):127-37. PubMed ID: 3618296
    [No Abstract]   [Full Text] [Related]  

  • 37. [Safety of immunoglobulins in view of the transmission of LAV/HTLV-III].
    Sugg U; Kaufmann R; Gürtler L; Schneider W
    Beitr Infusionther Klin Ernahr; 1987; 18():39-41. PubMed ID: 3326597
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 39. Possible nonspecific associations between malaria and HTLV-III/LAV.
    Biggar RJ
    N Engl J Med; 1986 Aug; 315(7):457-8. PubMed ID: 3016540
    [No Abstract]   [Full Text] [Related]  

  • 40. Acquired immune deficiency syndrome (AIDS) HTLV III/LAV; the causal agent and modes of transmission.
    Smithies A
    Health Bull (Edinb); 1986 Jul; 44(4):234-8. PubMed ID: 3017891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.